We are live on ! Find out more
OCRX

Ocera Therapeutics, Inc.
OCRX

Delisted

OCRX was delisted on the 8th of December, 2017.

Back to rankings

13 hedge funds and large institutions have $3.19M invested in Ocera Therapeutics, Inc. in 2013 Q2 according to their latest regulatory filings, with 13 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
+13
Holders Change %
–
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$1.27M +$1.4M +225,000 New
Jennison Associates
2
Jennison Associates
New York
$1.16M +$1.28M +206,265 New
QF
3
QVT Financial
New York
$538K +$593K +95,471 New
Renaissance Technologies
4
Renaissance Technologies
New York
$52K +$57K +9,182 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$47K +$51.8K +8,333 New
Deutsche Bank
6
Deutsche Bank
Germany
$39K +$43.1K +6,931 New
Geode Capital Management
7
Geode Capital Management
Massachusetts
$23K +$25.7K +4,140 New
Northern Trust
8
Northern Trust
Illinois
$20K +$21.9K +3,527 New
U
9
UBS
Switzerland
$16K +$17.5K +2,811 New
Citadel Advisors
10
Citadel Advisors
Florida
$12K +$13.4K +2,149 New
GC
11
Guggenheim Capital
Illinois
$9K +$10.1K +1,622 New
California Public Employees Retirement System
12
California Public Employees Retirement System
California
$1K +$1.32K +212 New
Bank of America
13
Bank of America
North Carolina
– +$311 +50 New

OCRX Hedge Fund Activity: Q2 2013 in Review

13 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Ocera Therapeutics, Inc. (OCRX) for Q2 2013, worth a combined $3.19M.

Buyers outnumbered sellers: 13 funds opened new OCRX positions and 0 closed out — a net gain of 13 holders — while 0 added to existing stakes and 0 trimmed.

  • 13 institutional investors held Ocera Therapeutics, Inc. (OCRX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $3.19M of Ocera Therapeutics, Inc. stock for Q2 2013.
  • 13 funds opened new Ocera Therapeutics, Inc. positions in Q2 2013 and 0 closed out, a net change of +13 holders.

Based on aggregated 13F filings for Q2 2013.